CRA-2059 TFA

CRA-2059 三氟乙酸

CRA-2059 TFA

C658831-5mg

5mg

≥99%

2-8°C储存,干燥

冰袋运输

CRA-2059 is a highly specific and selective tryptase inhibitor, with a K i of 620 pM for recombinant human tryptase-β (rHTβ). Appearance:Solid In Vitro:Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell secretory granules. CRA-2059 has the potential for inflammatory bowel disease research. MCE has not independently confirmed the accuracy of these methods Biological Activity:CRA-2059 is a highly specific and selective tryptase inhibitor, with a K i of 620 pM for recombinant human tryptase-β (rHTβ) .

C36H47F3N12O10

864.83 g/mol

NC(NC1=CC=C(CNC(N2CCN(C(O[C@@H]3COC4[C@H](OC(N5CCN(C(NCC6=CC=C(NC(N)=N)C=C6)=O)CC5)=O)COC34)=O)CC2)=O)C=C1)=N.FC(F)(F)C(O)=O

DMSO : 100 mg/mL (115.63 mM; Need ultrasonic)